article thumbnail

Vault Snack #30 – Additional Curve Fits for Plotting and Analysing Assay Data in CDD Vault

Collaborative Drug

The AUC will be calculated automatically and available by clicking Customize Your Report and selecting ‘Area under the curve’ from the protocol readout definition section. EC50, EC90) and Area Under the Curve, per plate or run, based on protocol definition. Its displayed for calculated intercepts (e.g.,

article thumbnail

The future of CNS drug development: signs of real progress

Drug Target Review

2 A raft of emerging therapeutic modalities sits at the centre of this boom, spanning advanced biologics, engineered platforms and next-generation small molecules. This protective barrier prevents more than 98 percent of small-molecule drugs and all macromolecular therapeutics 3 from accessing the brain.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

4 The definition has since evolved and expanded to include molecular signatures of pharmacodynamics and therapeutic response. Novel mechanisms of action associated with CGTs naturally create dosing effects that apply in very different ways than with traditional small molecule pharmacotherapies. 21(10):3517. Rodrigues AD.

article thumbnail

The Redevelopment of ChEBI

The ChEMBL-og

ChEBI has for the past >20 years provided the biological community with access to definitive small molecule information and data, including accurate representations of often complex chemical structures. It has a growing user base numbered in the hundreds of thousands and with millions of accesses each year.

article thumbnail

Flow state: The evolving shape of continuous manufacturing

Pharma Manufacturing

“It is a higher quality, higher kind of technology so that entails higher capital investment, which is definitely not an easy step for any company,” Halkude said. ” However, a significant amount of technological development is required for biologics processing, according to Halkude.

RNA
article thumbnail

Leadership in the Age of Stacks

LifeSciVC

This essay takes up those questions, not to provide definitive answers, but to explore the contours of a new leadership landscape. Not because they’re definitive, but because they feel aligned with the realities biotech leaders now face. One team might be working on a cell therapy, another on RNA, another on small molecules.

article thumbnail

Natural Intelligence?

Molecular Design

My pulse will be quickenin' With each drop of strychnine We feed to a pigeon It just takes a smidgin To poison a pigeon in the park Tom Lehrer, Poisoning Pigeons in the Park | video ** Ill be reviewing the H2024 study (Occurrence of Natural Selection in Successful Small Molecule Drug Discovery) in this post.